C.M. Bidwell & Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-2,194
Closed -$179K – 597
2023
Q2
$179K Buy
2,194
+29
+1% +$2.06K 0.13% 135
2023
Q1
$129K Buy
+2,165
New +$120K 0.1% 189
2022
Q4
– Sell
-35
Closed -$2K – 536
2022
Q3
$2K Sell
35
-10
-22% -$593 ﹤0.01% 436
2022
Q2
$2K Sell
45
-2,975
-99% -$207K ﹤0.01% 444
2022
Q1
$260K Hold
3,020
– – 0.17% 111
2021
Q4
$247K Buy
3,020
+45
+2% +$3.29K 0.15% 125
2021
Q3
$198K Sell
2,975
-60
-2% -$4.26K 0.13% 151
2021
Q2
$203K Buy
3,035
+1,350
+80% +$83.7K 0.13% 142
2021
Q1
$88K Buy
+1,685
New +$85.2K 0.06% 251

Other funds holding THC

C.M. Bidwell & Associates's THC Position: Q3 2023 in Review

C.M. Bidwell & Associates sold out of Tenet Healthcare (THC) in Q3 2023, closing a stake of 2,194 shares — an estimated $179K sold.

C.M. Bidwell & Associates first reported a position in THC in Q1 2021 and held it in 9 quarters. The position peaked at $260K in Q1 2022. 407 funds tracked by Wall St. Rank hold THC as of Q3 2023.

  • C.M. Bidwell & Associates reported no remaining Tenet Healthcare position as of Q3 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,194 Tenet Healthcare shares in Q3 2023, an estimated $179K.
  • C.M. Bidwell & Associates first reported a position in Tenet Healthcare in Q1 2021 and held it in 9 quarters.
  • C.M. Bidwell & Associates's Tenet Healthcare position peaked at $260K in Q1 2022.
  • 407 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2023, filed 13 Nov 2023.